hexamethonium has been researched along with shu 9119 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aizawa-Abe, M; Ebihara, K; Hayashi, T; Hosoda, K; Inoue, G; Iwai, H; Masuzaki, H; Matsuoka, N; Nakao, K; Ogawa, Y; Satoh, N; Yoshimasa, Y | 1 |
Mäkelä, S; Rinne, P; Savontaus, E; Streng, T; Tikka, S | 1 |
2 other study(ies) available for hexamethonium and shu 9119
Article | Year |
---|---|
Pathophysiological role of leptin in obesity-related hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; alpha-MSH; Animals; Blood Pressure; Body Weight; Eating; Energy Intake; Ganglionic Blockers; Heart; Heart Rate; Hexamethonium; Hypertension; Kidney; Leptin; Male; Melanocyte-Stimulating Hormones; Mice; Mice, Transgenic; Models, Biological; Obesity; Organ Size; Sympathetic Nervous System; Systole; Urine | 2000 |
Hemodynamic actions and mechanisms of systemically administered α-MSH analogs in mice.
Topics: alpha-MSH; Anesthetics; Animals; Blood Pressure; Consciousness; Dose-Response Relationship, Drug; Heart Rate; Hexamethonium; Male; Melanocyte-Stimulating Hormones; Metoprolol; Mice; Mice, Inbred C57BL; Peptides, Cyclic; Receptor, Melanocortin, Type 3; Receptor, Melanocortin, Type 4; Receptors, Corticotropin | 2012 |